Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hippocampal atrophy: another common pathogenic mechanism of depressive disorders and epilepsy?

Literature DB >> 22020737

Hippocampal atrophy: another common pathogenic mechanism of depressive disorders and epilepsy?

Andres M Kanner.

Abstract

Entities: Disease

Year: 2011 PMID： 22020737 PMCID： PMC3193098 DOI： 10.5698/1535-7511-11.5.149

Source DB: PubMed Journal: Epilepsy Curr ISSN： 1535-7511 Impact factor: 7.500

× No keyword cloud information.

12 in total

1. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.

Authors: John T O'Brien; Adrian Lloyd; Ian McKeith; Anil Gholkar; Nicol Ferrier
Journal: Am J Psychiatry Date: 2004-11 Impact factor: 18.112

2. Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures.

Authors: Andrey Finegersh; Christina Avedissian; Sadat Shamim; Irene Dustin; Paul M Thompson; William H Theodore
Journal: Epilepsia Date: 2011-01-26 Impact factor: 5.864

3. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients.

Authors: S Petrovski; C E I Szoeke; N C Jones; M R Salzberg; L J Sheffield; R M Huggins; T J O'Brien
Journal: Neurology Date: 2010-09-14 Impact factor: 9.910

Review 4. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Authors: R M Sapolsky
Journal: Arch Gen Psychiatry Date: 2000-10

5. Course of illness, hippocampal function, and hippocampal volume in major depression.

Authors: Glenda M MacQueen; Stephanie Campbell; Bruce S McEwen; Kathryn Macdonald; Shigeko Amano; Russell T Joffe; Claude Nahmias; L Trevor Young
Journal: Proc Natl Acad Sci U S A Date: 2003-01-24 Impact factor: 11.205

6. Hippocampal volume and 2-year outcome in depression.

Authors: Klaus-Thomas Kronmüller; Johannes Pantel; Sebastian Köhler; Daniela Victor; Frederik Giesel; Vincent A Magnotta; Christoph Mundt; Marco Essig; Johannes Schröder
Journal: Br J Psychiatry Date: 2008-06 Impact factor: 9.319

7. The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors.

Authors: Gaurav Kumar; Abbie Couper; Terence J O'Brien; Michael R Salzberg; Nigel C Jones; Sandra M Rees; Margaret J Morris
Journal: Psychoneuroendocrinology Date: 2007-07-05 Impact factor: 4.905

Hippocampal atrophy: another common pathogenic mechanism of depressive disorders and epilepsy?

1. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects.

2. Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures.

3. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients.

Review 4. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

5. Course of illness, hippocampal function, and hippocampal volume in major depression.

6. Hippocampal volume and 2-year outcome in depression.

7. The acceleration of amygdala kindling epileptogenesis by chronic low-dose corticosterone involves both mineralocorticoid and glucocorticoid receptors.

8. Predictors of pharmacoresistant epilepsy.

9. Hippocampal atrophy in recurrent major depression.

10. High-dimensional mapping of the hippocampus in depression.

Review 1. Resting state networks in temporal lobe epilepsy.

Review 2. Antidepressants for people with epilepsy and depression.